Literature DB >> 21567096

Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells.

Zhenying Guo1, Yuanzheng He, Shuangshuang Wang, Aixia Zhang, Ping Zhao, Chongfeng Gao, Brian Cao.   

Abstract

Hepatoma-derived growth factor (HDGF) has been implicated in the growth and metastasis of various types of human cancer, but the role of HDGF expression in prostate cancer or breast cancer has not been documented. To assess the role of HDGF in the proliferation, migration and invasion by prostate and breast cancer cells, HDGF expression in DU145 and MCF7 cells was knocked down using siRNA, and the effect of such knockdown was assessed by MTS and [3H]-thymidine incorporation Transwell assays. Moreover, we identified differentially expressed genes that might mediate the HDGF-induced cellular effects. Our results demonstrate that down-regulation of HDGF expression significantly reduces the proliferation of both DU145 and MCF7 cells. However, down-regulation of HDGF expression in DU145 inhibited cell migration and invasion, but in MCF7 cells it stimulated cell migration and invasion. This differential effect might result from the differential induction of PIK3R1 or SERPINE1 in the two cell lines upon HDGF-siRNA treatment. In conclusion, HDGF may participate in the pathogenesis of prostate and breast cancer by promoting cell growth and it may be a therapeutic target for these cancers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21567096     DOI: 10.3892/or.2011.1295

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.

Authors:  Dawei Li; Zhen Han; Jikai Liu; Xiang Zhang; Juchao Ren; Lei Yan; Hainan Liu; Zhonghua Xu
Journal:  Med Oncol       Date:  2013-09-03       Impact factor: 3.064

2.  Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.

Authors:  Sen Guo; Hong-da Liu; Yan-Feng Liu; Lei Liu; Qiang Sun; Xi-Jun Cui
Journal:  Tumour Biol       Date:  2014-09-28

3.  Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses.

Authors:  Joëlle V F Coumans; David Gau; Anne Poljak; Valerie Wasinger; Partha Roy; Pierre D J Moens
Journal:  OMICS       Date:  2014-12

Review 4.  Lipodystrophy-associated progeroid syndromes.

Authors:  David Araújo-Vilar; Antía Fernández-Pombo; Silvia Cobelo-Gómez; Ana I Castro; Sofía Sánchez-Iglesias
Journal:  Hormones (Athens)       Date:  2022-07-15       Impact factor: 3.419

5.  LncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer.

Authors:  Qiuhong Ma; Xiangqin Qi; Xiaona Lin; Liang Li; Libo Chen; Wei Hu
Journal:  Hum Cell       Date:  2019-10-04       Impact factor: 4.174

6.  The expression and clinical significance of HDGF in osteosarcoma.

Authors:  Zhiguo Chen; Shenghai Qiu; Xiaofei Lu
Journal:  Onco Targets Ther       Date:  2015-09-09       Impact factor: 4.147

7.  Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer.

Authors:  Xue-Jun Liu; Wen-Lian Liu; Fang-Mei Yang; Xiao-Qing Yang; Xiao-Fei Lu
Journal:  Onco Targets Ther       Date:  2015-08-13       Impact factor: 4.147

8.  Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.

Authors:  Feilong Yang; Nengwang Yu; Hui Wang; Cong Zhang; Zhao Zhang; Yanxiang Li; Dawei Li; Lei Yan; Hainan Liu; Zhonghua Xu
Journal:  PLoS One       Date:  2018-01-04       Impact factor: 3.240

9.  The evaluation of hepatoma-derived growth factor in determining of prognosis and estimating of invasive probability of tumoral cells, recurrent, and metastasis of lymphatic glands in breast carcinoma.

Authors:  Behrang Kazeminezhad; Behdad Baradaran; Mohammad Reza Hafezi Ahmadi
Journal:  J Family Med Prim Care       Date:  2017 Oct-Dec

10.  MicroRNA-425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma-derived growth factor.

Authors:  Wenyan Zhu; Yongchi Ma; Xuqin Zhuang; Xin Jin
Journal:  Oncol Lett       Date:  2018-02-27       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.